흉터 관리 시장 - 세계 및 지역별 분석 : 제품 유형별, 흉터 유형별, 최종사용자별, 국가별 - 분석과 예측(2025년-2035년)

Scar Management Market - A Global and Regional Analysis: Focus on Product, Scar Type, End User, and Country Analysis - Analysis and Forecast, 2025-2035

US $ 4,900 ￦ 7,129,000

PDF and Excel (1-3 User License)

PDF 및 Excel 보고서를 동일 사업장에서 3명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 7,500 ￦ 10,911,000

PDF and Excel (Global License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계 흉터 관리 시장 규모는 피부 관련 질환 증가, 미적 관심 증가, 피부과 치료의 발전, 외과 수술 증가 등을 배경으로 꾸준한 성장세를 보이고 있습니다.

이 시장에는 수술, 화상, 부상, 여드름, 튼살 등으로 인한 흉터를 최소화, 제거, 개선하기 위한 다양한 제품 및 치료법이 포함됩니다.

또한, 규제 발전, 지속적인 연구, 의료 전문가 및 업계 리더와의 전략적 제휴를 통해 흉터 치료의 혁신이 가속화되고 있습니다. 이러한 노력은 소비자의 요구를 충족시키기 위해 진화하는 세계 흉터 관리 시장의 유망한 궤적을 반영하고 있습니다. 인식의 향상, 기술 발전, 다양한 치료 옵션의 가용성은 향후 몇 년동안 흉터 관리 시장의 변화를 더욱 촉진할 것으로 예상됩니다.

제품별로는 실리콘 젤과 스프레이가 임상적으로 입증된 효과, 적용 용이성, 광범위한 가용성으로 인해 전 세계 흉터 관리 시장에서 독점적인 부문을 차지하고 있습니다. 이 제품들은 피부과 전문의와 성형외과 의사들이 비후성 흉터, 켈로이드, 수술 후 흉터 관리를 위해 널리 권장하고 있습니다. 그러나 실리콘 흉터 드레싱은 시장 성장을 더욱 가속화할 것으로 예상됩니다.

위축성 흉터는 여드름 흉터의 높은 유병률, 미용에 대한 관심 증가, 피부과 치료의 발전으로 인해 전 세계 흉터 관리 시장을 주도하고 있습니다. 위축성 흉터는 움푹 패이거나 함몰된 피부 흉터로 나타나며, 일반적으로 여드름, 수두, 외상, 수술 등으로 인해 발생하며 가장 널리 치료되는 흉터 중 하나입니다. 젊은 성인의 85% 가량이 여드름을 앓고 있어 많은 사람들이 효과적인 흉터 관리 솔루션을 찾고 있으며, 국소 치료, 레이저 치료, 미세침 치료, 화학적 필링, 피부 필러에 대한 수요를 촉진하고 있습니다.

세계 흉터 관리 시장을 주도하는 병원 부문은 수술 및 화상 치료 건수가 많고, 고급 흉터 관리 솔루션을 이용할 수 있기 때문에 병원 부문이 시장을 주도하고 있습니다. 병원은 수술 후 흉터 치료, 외상 관리, 특수 피부과 치료의 주요 센터 역할을 하고 있으며, 가장 큰 최종 사용자 부문입니다. 수술, 심한 화상 치료, 재건 수술을 받은 환자들은 실리콘 드레싱, 레이저 치료, 코르티코스테로이드 주사, 피부 이식 등 의료용 흉터 치료를 필요로 하는 경우가 많으며, 병원 환경에서 이러한 치료는 널리 활용되고 있습니다.

2024년 북미가 세계 흉터 관리 시장을 지배하고 있는 가운데, 2025-2035년의 예측 기간 동안 아시아태평양이 가장 높은 CAGR을 나타낼 것으로 예상됩니다. 북미는 세계 흉터 관리 시장에서 지배적인 위치를 차지하고 있으며, 그 주된 이유는 높은 수준의 의료 인프라, 높은 미용 인식, 수술 건수 증가에 기인합니다. 미국과 캐나다가 이 지역을 주도하고 있으며, 수술 후 흉터 관리가 필요한 수술을 포함한 미용 성형 및 재건 수술에 대한 수요 증가가 그 요인으로 작용하고 있습니다.

세계의 흉터 관리 시장에 대해 조사했으며, 시장 개요와 함께 시퀀싱 유형별/제품별/용도별/최종사용자별/지역별 동향, 시장 진출 기업 프로파일 등의 정보를 전해드립니다.

목차

주요 요약

제1장 세계의 흉터 관리 시장 : 업계 전망

• 시장 개요
• 주요 동향
• 공급망 분석
• 구입 채널
• 상환 시나리오
• 규제 상황

제2장 세계의 흉터 관리 시장 : 시장 역학

• 영향 분석
• 시장 성장 촉진요인
• 시장 성장 억제요인
• 시장 기회

제3장 세계의 흉터 관리 시장 분석(제품별), 100만 달러, 2024년-2035년

• 개요
• 실리콘 젤 및 스프레이
• 실리콘 드레싱
• 크림 및 연고
• 기타

제4장 세계의 흉터 관리 시장 분석(흉터 유형별), 100만 달러, 2024년-2035년

• 개요
• 위축성 흉터
• 비후성 흉터 및 켈로이드 흉터
• 기타

제5장 세계의 흉터 관리 시장 분석(최종사용자별), 100만 달러, 2024년-2035년

• 병원
• 전문 클리닉
• 재택 헬스케어

제6장 세계의 흉터 관리 시장 분석(지역별), 100만 달러, 2024년-2035년

• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 기타 지역

제7장 세계의 흉터 관리 시장 - 경쟁 벤치마킹과 기업 개요

• 경쟁 벤치마킹
• 경쟁 구도
  • 기업별 주요 전략과 전개
  • 주요 발전 분석
• 기업 개요
  • Advancis Medical
  • Bayer AG
  • B. Braun SE
  • Bio Med Sciences, Inc.
  • Covalon Technologies Ltd.
  • Derma E
  • Molnlycke Health Care AB
  • Newmedical Technology Inc
  • Quantum Health
  • Sonoma Pharmaceuticals, Inc
  • Stratpharma AG.
  • Scar Heal, Inc
  • Weigao Group.
  • Winner Medical Co., Ltd.

제8장 조사 방법

LSH

영문 목차

영문목차

Global Scar Management Market: Industry Overview

The global scar management market is experiencing steady growth, driven by rising incidences of skin-related conditions, increasing aesthetic concerns, advancements in dermatological treatments, and a growing number of surgical procedures. The market includes various products and treatments designed to minimize, eliminate, or improve the appearance of scars caused by surgical procedures, burns, injuries, acne, and stretch marks.

Additionally, regulatory advancements, continuous research, and strategic collaborations between medical professionals and industry leaders are accelerating innovation in scar treatment. These efforts reflect a promising trajectory for the global scar management market as it evolves to meet consumer needs. Increasing awareness, technological advancements, and the availability of diverse treatment options are expected to further drive scar management market transformation in the coming years.

Market Segmentation:

Segmentation 1: by Product

• Silicone gel and spray
• Silicone Dressing
• Cream and Ointments
• Others

Silicone Gel and Spray to Continue its Dominance in the Product Segment

Based on product, silicone gels and sprays, have emerged as the dominant segment in the global scar management market due to their proven clinical efficacy, ease of application, and widespread availability. These products are widely recommended by dermatologists and plastic surgeons for managing hypertrophic scars, keloids, and post-surgical scars. However, silicone scar dressing is further expected to accelerate the market growth.

Segmentation 2: by Scar Type

• Atrophic Scars
• Hypertrophic and Keloid Scars
• Others

Atrophic Scars to Continue its Dominance in the Scar Type Segment

The atrophic scars segment dominates the global scar management market, primarily due to the high prevalence of acne scars, rising aesthetic consciousness, and advancements in dermatological treatments. Atrophic scars, which appear as depressed or sunken skin marks, commonly result from acne, chickenpox, trauma, or surgery, making them one of the most widely treated scar types. With acne affecting nearly 85% of young adults, a significant number of individuals seek effective scar management solutions, fuelling demand for topical treatments, laser therapy, microneedling, chemical peels, and dermal fillers.

Segmentation 3: by End User

• Hospitals
• Specialty Clinics
• Home Healthcare

Hospitals to Continue its Dominance in the End User Segment

The hospital segment dominates the global scar management market, primarily due to the high volume of surgical procedures, burn treatments, and access to advanced scar management solutions. Hospitals serve as the primary centers for post-surgical scar care, trauma management, and specialized dermatological treatments, making them the largest end-user segment. Patients undergoing surgeries, severe burn treatments, and reconstructive procedures often require medical-grade scar therapies, including silicone dressings, laser treatments, corticosteroid injections, and skin grafting, which are widely available in hospital settings.

Segmentation 5: by Region

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Russia
  • Ireland
  • Belgium
  • Portugal
  • Netherlands
  • Switzerland
  • Finland
  • Czech Republic
  • Norway
  • Denmark
  • Sweden
  • Rest-of-Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • Singapore
  • South Korea
  • Thailand
  • Rest-of-Asia-Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Rest-of-Latin America
• Rest-of-the-World

In 2024, the North America region dominated the global scar management market; however, the Asia-Pacific region is expected to register the highest CAGR during the forecast period 2025-2035. North America holds the dominant position in the global scar management market, primarily due to its advanced healthcare infrastructure, high aesthetic awareness, and increasing number of surgical procedures. The U.S. and Canada lead the region, driven by rising demand for cosmetic and reconstructive surgeries, including procedures that require post-surgical scar management.

Recent Developments in the Global Scar Management Market

• In October 2022, Foshan United Medical Technologies Ltd. collaborated with both business and regulatory bodies to develop standardized product norms for silicone scar gel products. The culmination of this effort resulted in the creation of a scientific paper titled "The Evaluation and its Method on Moisture Retention of Silicone Scar Gel."
• In August 2021, Merz Therapeutics and Acino signed a distribution agreement in Ukraine, CIS, and Mongolia. Acino would be responsible for commercializing Merz Therapeutics' product portfolio, covering areas such as hepatic encephalopathy, Parkinson's disease, scar, and hair treatment.
• In September 2021, Sonoma Pharmaceuticals, Inc. launched three innovative products for consumers. These products, namely, Regenacyn advanced scar gel, Ocucyn eyelid, and eyelash cleanser, were made available for purchase without a prescription, making them easily accessible to consumers.

Demand - Drivers, Restraints and Opportunities

Market Demand Drivers:

• Rising Incidence of Burn and Trauma Injuries: The increasing incidence of burn and trauma injuries is a significant driver of the scar management market, as these injuries often result in severe scarring that requires specialized treatment. Burns, whether caused by fire, chemicals, radiation, or electrical exposure, can lead to hypertrophic and contracture scars, which can impact mobility, functionality, and aesthetic appearance. Similarly, traumatic injuries from road accidents, workplace incidents, and violence-related wounds frequently cause deep tissue damage, necessitating advanced scar management solutions to enhance healing and minimize long-term skin damage. According to the World Health Organization (WHO), burns cause approximately 180,000 deaths annually, with a significant proportion of survivors experiencing permanent scarring and disfigurement.
• Increasing Concern Among People Regarding their Aesthetic Appearance: The increasing concern for aesthetic appearance is a key factor fuelling the growth of the scar management market, as individuals seek effective solutions to reduce or eliminate visible scars caused by acne, surgeries, injuries, burns, and stretch marks. In today's image-conscious society, the rising influence of social media, beauty standards, and self-confidence awareness has led more people to explore advanced scar treatments to improve their skin's appearance.

Market Restraints:

• High Procedural Costs Associated with Scar Treatments and Management Solutions: The high procedural costs associated with scar treatments and management solutions present a significant challenge to the growth of the scar management market, limiting access to advanced and effective treatment options for many patients. While technological advancements have led to the development of innovative scar management solutions, such as laser therapy, microneedling, platelet-rich plasma (PRP) therapy, and stem cell-based treatments, these procedures often come with high price tags, making them inaccessible to a large segment of the population.

Market Opportunities:

• Emergence of Remote Monitoring and Digital Health Solutions: Advances in technology and ongoing research and development efforts offer the potential for innovative and more efficient solutions to emerge, creating opportunities for companies to differentiate themselves. These advancements can further contribute to the overall growth of the scar management market.

How can this report add value to an organization?

Workflow/Innovation Strategy: The scar management market (by scar type) comprises atrophic scars, hypertrophic and keloid scars, contracture scars, and stretch marks. Moreover, the study provides the reader with a detailed understanding of the various types of scars and associated products tailored to address these scars.

Growth/Marketing Strategy: The scar management market's growth strategy includes innovation, expansion into emerging markets, collaboration with healthcare professionals, and regulatory streamlining. These efforts aim to enhance accessibility and meet the diverse needs of consumers.

Competitive Strategy: Key players in the global scar management market have been analyzed and profiled in the study, including new product launches and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the global scar management market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

• The base year considered for the calculation of the scar management market size is 2024. The historical year analysis has been done from FY2021 to FY2023, and the market size has been calculated for FY2024 and projected for the period 2025-2035.
• The geographical distribution of the market revenue is estimated to be the same as the company's net revenue distribution. All the numbers are adjusted to two digits after decimals for report presentation reasons. However, the real figures have been utilized for compound annual growth rate (CAGR) estimation. CAGR is calculated from 2025 to 2035.
• The market has been mapped based on different types of products available in the market and based on several indications. All the key manufacturing companies that have a significant number of offerings to the long-acting drug delivery technologies and services market have been considered and profiled in the report.
• In the study, the primary respondent's verification has been considered to finalize the estimated market for the long-acting drug delivery technologies and services market.
• The latest annual reports of each market player have been taken into consideration for market revenue calculation.
• The base currency considered for the market analysis is US$. Currencies other than the US$ have been converted to the US$ for all statistical calculations, considering the average conversion rate for that particular year. The currency conversion rate has been taken from the historical exchange rate of the Oanda website.

Primary Research

The key data points taken from the primary sources include:

• Validation and triangulation of all the numbers and graphs
• Validation of the report's segmentation and key qualitative findings
• Understanding of the numbers of the various markets for market type
• Percentage split of individual markets for regional analysis

Secondary Research

Open Sources

• Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), World Health Organization (WHO), International Society for Dermatology (ISD), American Academy of Dermatology (AAD), International Association for Scar Management (IASM), and European Dermatology Forum (EDF), and among others.
• Annual reports, SEC filings, and investor presentations of the leading market players
• Company websites and detailed study of their portfolio
• Gold standard magazines, journals, whitepapers, press releases, and news articles
• Databases

The key data points taken from the secondary sources include:

• Segmentations, split-ups, and percentage shares
• Data for market value
• Key industry trends of the top players in the market
• Qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
• Quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The global scar management market is witnessing substantial growth, driven by rising awareness of scar-related concerns, advancements in medical technologies, and increasing demand for aesthetics and treatments. The scar management market encompasses a diverse range of products aimed at improving both the appearance and functionality of scars resulting from injuries, surgeries, burns, and medical conditions. Among the widely used solutions, silicone sheets, scar gels, creams, and ointments stand out as popular over-the-counter (OTC) scar management products, offering convenience and self-administration options.

The expansion of the scar management market is fuelled by factors such as the rising incidence of burn injuries, an increasing number of surgical procedures, and a growing prevalence of traumatic injuries, all of which contribute to the demand for effective scar treatment solutions. The scar management market is segmented into various categories, including product type, scar type, and end users, reflecting the growing diversification in treatment options and consumer preferences. As innovations continue to shape the scar management market, emerging technologies and professional treatments are expected to further drive its evolution and accessibility.

Some of the prominent companies in the scar management market are:

• Bayer AG
• B. Braun SE
• Advancis Medical
• Molnlycke Health Care AB
• Winner Medical Co., Ltd.
• Weigao Group
• Bio Med Sciences
• Sonoma Pharmaceuticals, Inc.
• Covalon Technologies Ltd.
• Stratpharma Switzerland
• Derma E
• Newmedical Technology Inc.
• Quantum Health

Companies that are not a part of the aforementioned pool have been well-represented across different sections of the report (wherever applicable).

Table of Contents

Executive Summary

Scope of the Study

Market/Product Definition

Inclusion and Exclusion Criteria

1. Global Scar Management Market: Industry Outlook

• 1.1 Market Overview
• 1.2 Key Trends
• 1.3 Supply Chain Analysis
• 1.4 Purchasing Channels
• 1.5 Reimbursement Scenario
• 1.6 Regulatory Landscape

2. Global Scar Management Market: Market Dynamics

• 2.1.1 Impact Analysis
• 2.1.2 Market Drivers
• 2.1.3 Market Restraints
• 2.1.4 Market Opportunities

3. Global Scar Management Market Analysis (By Product), $Million, 2024-2035

• 3.1 Overview
• 3.2 Silicon Gel and Spray
• 3.3 Silicon Dressings
• 3.4 Cream and Ointments
• 3.5 Others

4. Global Scar Management Market Analysis (By Scar Type), $Million, 2024-2035

• 4.1 Overview
• 4.2 Atrophic Scars
• 4.3 Hypertrophic and Keloid Scars
• 4.4 Others

5. Global Scar Management Market Analysis (By End User), $Million, 2024-2035

• 5.1 Hospitals
• 5.2 Specialty Clinics
• 5.3 Home Healthcare

6. Global Scar Management Market Analysis (By Region), $Million, 2024-2035

• 6.1 North America
  • 6.1.1 Market Dynamics
  • 6.1.2 Market Sizing and Forecast
    • 6.1.2.1 By Product
    • 6.1.2.2 By Scar Type
    • 6.1.2.3 By End User
    • 6.1.2.4 By Country
      • 6.1.2.4.1 U.S.
        • 6.1.2.4.1.1 Market Dynamics
        • 6.1.2.4.1.2 Market Sizing and Forecast
        • 6.1.2.4.1.2.1 U.S. Scar Management Market, by Product
      • 6.1.2.4.2 Canada
        • 6.1.2.4.2.1 Market Dynamics
        • 6.1.2.4.2.2 Market Sizing and Forecast
        • 6.1.2.4.2.2.1 Canada Scar Management Market, by Product
• 6.2 Europe
  • 6.2.1 Market Dynamics
  • 6.2.2 Market Sizing and Forecast
    • 6.2.2.1 By Product
    • 6.2.2.2 By Scar Type
    • 6.2.2.3 By End User
    • 6.2.2.4 By Country
      • 6.2.2.4.1 U.K.
        • 6.2.2.4.1.1 Market Dynamics
        • 6.2.2.4.1.2 Market Sizing and Forecast
        • 6.2.2.4.1.2.1 U.K. Scar Management Market, by Product
      • 6.2.2.4.2 Germany
        • 6.2.2.4.2.1 Market Dynamics
        • 6.2.2.4.2.2 Market Sizing and Forecast
        • 6.2.2.4.2.2.1 Germany Scar Management Market, by Product
      • 6.2.2.4.3 France
        • 6.2.2.4.3.1 Market Dynamics
        • 6.2.2.4.3.2 Market Sizing and Forecast
        • 6.2.2.4.3.2.1 France Scar Management Market, by Product
      • 6.2.2.4.4 Italy
        • 6.2.2.4.4.1 Market Dynamics
        • 6.2.2.4.4.2 Market Sizing and Forecast
        • 6.2.2.4.4.2.1 Italy Scar Management Market, by Product
      • 6.2.2.4.5 Spain
        • 6.2.2.4.5.1 Market Dynamics
        • 6.2.2.4.5.2 Market Sizing and Forecast
        • 6.2.2.4.5.2.1 Spain Scar Management Market, by Product
      • 6.2.2.4.6 Russia
        • 6.2.2.4.6.1 Market Dynamics
        • 6.2.2.4.6.2 Market Sizing and Forecast
        • 6.2.2.4.6.2.1 Russia Scar Management Market, by Product
      • 6.2.2.4.7 Ireland
        • 6.2.2.4.7.1 Market Dynamics
        • 6.2.2.4.7.2 Market Sizing and Forecast
        • 6.2.2.4.7.2.1 Ireland Scar Management Market, by Product
      • 6.2.2.4.8 Belgium
        • 6.2.2.4.8.1 Market Dynamics
        • 6.2.2.4.8.2 Market Sizing and Forecast
        • 6.2.2.4.8.2.1 Belgium Scar Management Market, by Product
      • 6.2.2.4.9 Portugal
        • 6.2.2.4.9.1 Market Dynamics
        • 6.2.2.4.9.2 Market Sizing and Forecast
        • 6.2.2.4.9.2.1 Portugal Scar Management Market, by Product
      • 6.2.2.4.10 Netherlands
        • 6.2.2.4.10.1 Market Dynamics
        • 6.2.2.4.10.2 Market Sizing and Forecast
        • 6.2.2.4.10.2.1 Netherlands Scar Management Market, by Product
      • 6.2.2.4.11 Switzerland
        • 6.2.2.4.11.1 Market Dynamics
        • 6.2.2.4.11.2 Market Sizing and Forecast
        • 6.2.2.4.11.2.1 Switzerland Scar Management Market, by Product
      • 6.2.2.4.12 Norway
        • 6.2.2.4.12.1 Market Dynamics
        • 6.2.2.4.12.2 Market Sizing and Forecast
        • 6.2.2.4.12.2.1 Norway Scar Management Market, by Product
      • 6.2.2.4.13 Denmark
        • 6.2.2.4.13.1 Market Dynamics
        • 6.2.2.4.13.2 Market Sizing and Forecast
        • 6.2.2.4.13.2.1 Denmark Scar Management Market, by Product
      • 6.2.2.4.14 Sweden
        • 6.2.2.4.14.1 Market Dynamics
        • 6.2.2.4.14.2 Market Sizing and Forecast
        • 6.2.2.4.14.2.1 Sweden Scar Management Market, by Product
      • 6.2.2.4.15 Czech Republic
        • 6.2.2.4.15.1 Market Dynamics
        • 6.2.2.4.15.2 Market Sizing and Forecast
        • 6.2.2.4.15.2.1 Czech Republic Scar Management Market, by Product
      • 6.2.2.4.16 Finland
        • 6.2.2.4.16.1 Market Dynamics
        • 6.2.2.4.16.2 Market Sizing and Forecast
        • 6.2.2.4.16.2.1 Finland Scar Management Market, by Product
      • 6.2.2.4.17 Rest of Europe
        • 6.2.2.4.17.1 Market Dynamics
        • 6.2.2.4.17.2 Market Sizing and Forecast
        • 6.2.2.4.17.2.1 Rest of Europe Scar Management Market, by Product
• 6.3 Asia Pacific
  • 6.3.1 Market Dynamics
  • 6.3.2 Market Sizing and Forecast
    • 6.3.2.1 By Product
    • 6.3.2.2 By Scar Type
    • 6.3.2.3 By End User
    • 6.3.2.4 By Country
      • 6.3.2.4.1 Japan
        • 6.3.2.4.1.1 Market Dynamics
        • 6.3.2.4.1.2 Market Sizing and Forecast
        • 6.3.2.4.1.2.1 Japan Scar Management Market, by Product
      • 6.3.2.4.2 China
        • 6.3.2.4.2.1 Market Dynamics
        • 6.3.2.4.2.2 Market Sizing and Forecast
        • 6.3.2.4.2.2.1 China Scar Management Market, by Product
      • 6.3.2.4.3 India
        • 6.3.2.4.3.1 Market Dynamics
        • 6.3.2.4.3.2 Market Sizing and Forecast
        • 6.3.2.4.3.2.1 India Scar Management Market, by Product
      • 6.3.2.4.4 Australia
        • 6.3.2.4.4.1 Market Dynamics
        • 6.3.2.4.4.2 Market Sizing and Forecast
        • 6.3.2.4.4.2.1 Australia Scar Management Market, by Product
      • 6.3.2.4.5 Singapore
        • 6.3.2.4.5.1 Market Dynamics
        • 6.3.2.4.5.2 Market Sizing and Forecast
        • 6.3.2.4.5.2.1 Singapore Scar Management Market, by Product
      • 6.3.2.4.6 South Korea
        • 6.3.2.4.6.1 Market Dynamics
        • 6.3.2.4.6.2 Market Sizing and Forecast
        • 6.3.2.4.6.2.1 South Korea Scar Management Market, by Product
      • 6.3.2.4.7 Thailand
        • 6.3.2.4.7.1 Market Dynamics
        • 6.3.2.4.7.2 Market Sizing and Forecast
        • 6.3.2.4.7.2.1 Singapore Scar Management Market, by Product
      • 6.3.2.4.8 Rest-of -Asia-Pacific
        • 6.3.2.4.8.1 Market Dynamics
        • 6.3.2.4.8.2 Market Sizing and Forecast
        • 6.3.2.4.8.2.1 Rest-of-Asia-Pacific Scar Management Market, by Product
• 6.4 Latin America
  • 6.4.1 Market Dynamics
  • 6.4.2 Market Sizing and Forecast
    • 6.4.2.1 By Product
    • 6.4.2.2 By Scar Type
    • 6.4.2.3 By End User
    • 6.4.2.4 By Country
      • 6.4.2.4.1 Brazil
        • 6.4.2.4.1.1 Market Dynamics
        • 6.4.2.4.1.2 Market Sizing and Forecast
        • 6.4.2.4.1.2.1 Brazil Scar Management Market, by Product
      • 6.4.2.4.2 Mexico
        • 6.4.2.4.2.1 Market Dynamics
        • 6.4.2.4.2.2 Market Sizing and Forecast
        • 6.4.2.4.2.2.1 Mexico Scar Management Market, by Product
      • 6.4.2.4.3 Argentina
        • 6.4.2.4.3.1 Market Dynamics
        • 6.4.2.4.3.2 Market Sizing and Forecast
        • 6.4.2.4.3.2.1 Argentina Scar Management Market, by Product
      • 6.4.2.4.4 Chile
        • 6.4.2.4.4.1 Market Dynamics
        • 6.4.2.4.4.2 Market Sizing and Forecast
        • 6.4.2.4.4.2.1 Chile Scar Management Market, by Product
      • 6.4.2.4.5 Rest-of-Latin America
        • 6.4.2.4.5.1 Market Dynamics
        • 6.4.2.4.5.2 Market Sizing and Forecast
        • 6.4.2.4.5.2.1 Rest-of -Latin America Scar Management Market, by Product
• 6.5 Rest-of-the-World
  • 6.5.1 Market Dynamics
  • 6.5.2 Market Sizing and Forecast
    • 6.5.2.1 By Product
    • 6.5.2.2 By Scar Type
    • 6.5.2.3 By End User
    • 6.5.2.4 By Country

7. Global Scar Management Market - Competitive Benchmarking and Company Profiles

• 7.1 Competitive Benchmarking
• 7.2 Competitive Landscape
  • 7.2.1 Key Strategies and Developments by Company
    • 7.2.1.1 Funding Activities
    • 7.2.1.2 Mergers and Acquisitions
    • 7.2.1.3 Regulatory Approvals
    • 7.2.1.4 Partnerships, Collaborations, and Business Expansions
  • 7.2.2 Key Developments Analysis
• 7.3 Company Profiles
  • 7.3.1 Advancis Medical
  • 7.3.2 Bayer AG
  • 7.3.3 B. Braun SE
  • 7.3.4 Bio Med Sciences, Inc.
  • 7.3.5 Covalon Technologies Ltd.
  • 7.3.6 Derma E
  • 7.3.7 Molnlycke Health Care AB
  • 7.3.8 Newmedical Technology Inc
  • 7.3.9 Quantum Health
  • 7.3.10 Sonoma Pharmaceuticals, Inc
  • 7.3.11 Stratpharma AG.
  • 7.3.12 Scar Heal, Inc
  • 7.3.13 Weigao Group.
  • 7.3.14 Winner Medical Co., Ltd.

8. Research Methodology

관련자료